GENPREX INC (GNPX) Fundamental Analysis & Valuation

NASDAQ:GNPX • US3724463027

Current stock price

1.94 USD
+0.05 (+2.65%)
At close:
1.9386 USD
0 (-0.07%)
After Hours:

This GNPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GNPX Profitability Analysis

1.1 Basic Checks

  • GNPX had negative earnings in the past year.
  • GNPX had a negative operating cash flow in the past year.
  • GNPX had negative earnings in each of the past 5 years.
  • In the past 5 years GNPX always reported negative operating cash flow.
GNPX Yearly Net Income VS EBIT VS OCF VS FCFGNPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • GNPX's Return On Assets of -458.87% is on the low side compared to the rest of the industry. GNPX is outperformed by 93.64% of its industry peers.
  • GNPX's Return On Equity of -1262.44% is on the low side compared to the rest of the industry. GNPX is outperformed by 80.92% of its industry peers.
Industry RankSector Rank
ROA -458.87%
ROE -1262.44%
ROIC N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
GNPX Yearly ROA, ROE, ROICGNPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GNPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GNPX Yearly Profit, Operating, Gross MarginsGNPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GNPX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for GNPX has been increased compared to 1 year ago.
  • GNPX has more shares outstanding than it did 5 years ago.
  • GNPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GNPX Yearly Shares OutstandingGNPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K
GNPX Yearly Total Debt VS Total AssetsGNPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • GNPX has an Altman-Z score of -73.75. This is a bad value and indicates that GNPX is not financially healthy and even has some risk of bankruptcy.
  • GNPX's Altman-Z score of -73.75 is on the low side compared to the rest of the industry. GNPX is outperformed by 93.06% of its industry peers.
  • GNPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -73.75
ROIC/WACCN/A
WACCN/A
GNPX Yearly LT Debt VS Equity VS FCFGNPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 0.84 indicates that GNPX may have some problems paying its short term obligations.
  • GNPX has a worse Current ratio (0.84) than 87.48% of its industry peers.
  • A Quick Ratio of 0.84 indicates that GNPX may have some problems paying its short term obligations.
  • GNPX has a worse Quick ratio (0.84) than 87.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
GNPX Yearly Current Assets VS Current LiabilitesGNPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GNPX Growth Analysis

3.1 Past

  • GNPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.15%, which is quite impressive.
EPS 1Y (TTM)60.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • GNPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.33% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNPX Yearly Revenue VS EstimatesGNPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 50M 100M 150M
GNPX Yearly EPS VS EstimatesGNPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 -500 -1K -1.5K

More info and screens

Find the best growth stocksShow best growing peers

1

4. GNPX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GNPX. In the last year negative earnings were reported.
  • Also next year GNPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNPX Price Earnings VS Forward Price EarningsGNPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNPX Per share dataGNPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300 -400

4.3 Compensation for Growth

  • GNPX's earnings are expected to grow with 41.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.33%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GNPX Dividend Analysis

5.1 Amount

  • No dividends for GNPX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GNPX Fundamentals: All Metrics, Ratios and Statistics

GENPREX INC

NASDAQ:GNPX (3/25/2026, 8:00:02 PM)

After market: 1.9386 0 (-0.07%)

1.94

+0.05 (+2.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners0.41%
Inst Owner Change-99.49%
Ins Owners3.62%
Ins Owner Change5.82%
Market Cap4.50M
Revenue(TTM)N/A
Net Income(TTM)-17.56M
Analysts82.86
Price TargetN/A
Short Float %31.96%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-453.5
EYN/A
EPS(NY)-1.17
Fwd EYN/A
FCF(TTM)-6.07
FCFYN/A
OCF(TTM)-6.07
OCFYN/A
SpS0
BVpS0.6
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -458.87%
ROE -1262.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -73.75
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)236.4%
Cap/Depr(5y)318.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.36%
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.59%
OCF growth 3YN/A
OCF growth 5YN/A

GENPREX INC / GNPX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GENPREX INC (GNPX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNPX.


Can you provide the valuation status for GENPREX INC?

ChartMill assigns a valuation rating of 1 / 10 to GENPREX INC (GNPX). This can be considered as Overvalued.


What is the profitability of GNPX stock?

GENPREX INC (GNPX) has a profitability rating of 0 / 10.


What is the expected EPS growth for GENPREX INC (GNPX) stock?

The Earnings per Share (EPS) of GENPREX INC (GNPX) is expected to grow by 99.72% in the next year.